Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
22:38:43 EDT Mon 07 Oct 2024
Enter Symbol
or Name
USA
CA



Q:DGNOF - DIAGNOS INC - http://www.diagnos.ca
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
DGNOF - Qnot subscribed0.2471-0.01169-4.521.8590.2501  0.2575  0.24710.3841  0.17511:54:51Oct 0315 min RT 2¢

Recent Trades - All 9 today
Time ETExPriceChangeVolume
11:54:51Q0.2471-0.011692,500
10:21:40Q0.25-0.008792,500
10:21:38Q0.25-0.008792,800
10:21:38Q0.25-0.008792,600
10:09:25Q0.2575-0.001292,200
10:09:24Q0.25-0.008792,200
10:09:03Q0.25-0.008792,400
10:08:28Q0.2575-0.001292,100
10:08:07Q0.2501-0.008692,500
     

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-10-03 15:30U:DGNOFNews ReleaseDIAGNOS Announces Grant of Stock Options
2024-09-26 12:09U:DGNOFNews ReleaseDIAGNOS Announces Voting Results of Meeting of Shareholders
2024-09-23 16:29U:DGNOFNews ReleaseDIAGNOS Announces Variation in One Insider Ownership
2024-09-20 15:54U:DGNOFNews ReleaseDIAGNOS Announces Closing of Private Placement
2024-08-22 15:45U:DGNOFNews ReleaseDIAGNOS Announces Date of Annual General and Special Meeting of Shareholders
2024-08-20 09:45U:DGNOFNews ReleaseDIAGNOS Successfully Completes ISO 13485 / MDSAP Audit and receives its certification to move forward with FDA and Health Canada
2024-06-05 17:07U:DGNOFNews ReleaseDIAGNOS Announces Closing of Second and Final Tranche of Private Placement
2024-05-21 09:00U:DGNOFNews ReleaseDIAGNOS celebrates the launch of Labtician's new screening service for diabetic retinopathy in Ontario and renews its distribution agreement
2024-05-09 16:15U:DGNOFNews ReleaseDIAGNOS Announces Closing of First Tranche of Private Placement
2024-05-06 09:00U:DGNOFNews ReleaseDIAGNOS to Present Cutting-Edge AI Solutions for Retinal Health at ARVO 2024
2024-04-16 11:08U:DGNOFNews ReleaseDIAGNOS to expedite application for Medical Device License to Health Canada and US FDA related to its 4 new analysis modules, and is planning ISO 27001 certification
2024-04-09 10:11U:DGNOFNews ReleaseDIAGNOS Inc. to Present at the AI & Technology Hybrid Investor Conference April 11th
2024-04-03 14:13U:DGNOFNews ReleaseDIAGNOS Announces Grant of Stock Options
2024-04-02 10:00U:DGNOFNews ReleaseDIAGNOS Welcomes Dr. Philippe Couillard to its Board of Directors
2024-03-22 16:17U:DGNOFNews ReleaseDIAGNOS Announces Closing of Second and Final Tranche of Private Placement
2024-03-04 15:45U:DGNOFNews ReleaseDIAGNOS Announces Grant of Stock Options
2024-02-29 11:11U:DGNOFNews ReleaseDIAGNOS Welcomes Mr. Michael Braeuel to its Board of Directors
2024-02-27 16:14U:DGNOFNews ReleaseDIAGNOS Announces Closing of First Tranche of Private Placement
2024-02-23 15:50U:DGNOFNews ReleaseDiagnos Announces Variation in One Insider Ownership of Common Shares